KMDA
NASDAQ · Biotechnology
Kamada Ltd
$6.87
-0.55 (-7.41%)
Open$7.01
Previous Close$7.42
Day High$7.12
Day Low$6.77
52W High$9.35
52W Low$6.55
Volume—
Avg Volume127.5K
Market Cap414.82M
P/E Ratio18.64
EPS$0.38
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+322.4% upside
Current
$6.87
$6.87
Target
$29.02
$29.02
$25.25
$29.02 avg
$47.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 160.33M | 159.43M | 67.17M |
| Net Income | 20.90M | 18.71M | -1,989,318 |
| Profit Margin | 5.8% | 5.5% | -3.0% |
| EBITDA | 29.27M | 27.65M | -2,803,887 |
| Free Cash Flow | — | — | -2,727,774 |
| Rev Growth | +0.6% | +0.6% | +14.3% |
| Debt/Equity | 0.04 | 0.04 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |